Life Spine Prolift expandable interbody system receives FDA clearance


The US Food and Drug Administration (FDA) has given 510(k) marketing clearance to Life Spine for the Prolift expandable interbody system.

The all-titanium Prolift system is designed to restore disc height, in-situ, for minimally invasive posterior lateral interbody fusion, transforaminal lateral interbody fusion and oblique approaches.

“The Prolift expandable interbody system allows for simplified, contracted insertion with minimal anatomical disruption and retraction. Once implanted, it can expand cephalad to caudal to accommodate disc height ranges from 8mm to 16mm for varying patient anatomy. When paired with the Centerline midline thoracolumbar screw system, Prolift creates the optimal hyper-minimally invasive solution,” says Rich Mueller, chief operating officer.

Prolift is scheduled for limited release in the second quarter of 2016, with full product release expected later in the year.